INVO BioScience(INVO) - 2020 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION (State or other jurisdiction of incorporation or organization) WASHINGTON, D.C. 20549 FORM 10-K ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2020 INVO BIOSCIENCE, INC. (Exact name of registrant as specified in Charter) or Nevada 001-39701 20-4036208 (Commis ...